Slowly Progressive Type 1 Diabetes Mellitus: Current Knowledge And Future Perspectives

References

• Kobayashi T , Itoh T , Kosaka K , Sato K , Tsuji K . Time course of islet cell antibodies and beta-cell function in non-insulin-dependent stage of type I diabetes. Diabetes . 1987;36(4):510–517. doi:10.2337/diab.36.4.510 3545950
   PubMed Web of Science ®Google Scholar
• Kobayashi T , Nakanishi K , Sugimoto T , et al. Maleness as risk factor for slowly progressive IDDM. Diabetes Care . 1989;12(1):7–11. doi:10.2337/diacare.12.1.7 2653752
   PubMed Web of Science ®Google Scholar
• Kobayashi T , Tamemoto K , Nakanishi K , et al. Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care . 1993;16(5):780–788. doi:10.2337/diacare.16.5.780 8098691
   PubMed Web of Science ®Google Scholar
• Kobayashi T . Subtype of insulin-dependent diabetes mellitus (IDDM) in Japan: slowly progressive IDDM–the clinical characteristics and pathogenesis of the syndrome. Diabetes Res Clin Pract . 1994;24(Suppl):S95–S99. doi:10.1016/0168-8227(94)90234-8 7859641
   PubMed Web of Science ®Google Scholar
• Stenstrom G , Gottsater A , Bakhtadze E , Berger B , Sundkvist G . Latent autoimmune diabetes in adults: definition, prevalence, beta-cell function, and treatment. Diabetes . 2005;54(Suppl 2):S68–S72. doi:10.2337/diabetes.54.suppl_2.S68 16306343
   PubMed Web of Science ®Google Scholar
• Leslie RD , Palmer J , Schloot NC , Lernmark A . Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment. Diabetologia . 2016;59(1):13–20. doi:10.1007/s00125-015-3789-z 26498592
   PubMed Web of Science ®Google Scholar
• Kobayashi T , Tanaka S , Harii N , et al. Immunopathological and genetic features in slowly progressive insulin-dependent diabetes mellitus and latent autoimmune diabetes in adults. Ann N Y Acad Sci . 2006;1079:60–66. doi:10.1196/annals.1375.009 17130533
   PubMed Web of Science ®Google Scholar
• Pozzilli P , Guglielmi C . Immunomodulation for the prevention of SPIDDM and LADA. Ann N Y Acad Sci . 2006;1079:90–98. doi:10.1196/annals.1375.012 17130536
   PubMed Web of Science ®Google Scholar
• Tanaka S , Ohmori M , Awata T , et al. Diagnostic criteria for slowly progressive insulin-dependent (type 1) diabetes mellitus (SPIDDM) (2012): report by the Committee on Slowly Progressive Insulin-Dependent (Type 1) Diabetes Mellitus of the Japan Diabetes Society. Diabetol Int 2015;6(1):1–7.
   Google Scholar
• Kobayashi T , Nakanishi K , Okubo M , Murase T , Kosaka K . GAD antibodies seldom disappear in slowly progressive IDDM. Diabetes Care . 1996;19(9):1031. doi:10.2337/diacare.19.9.1031a
   Web of Science ®Google Scholar
• Maruyama T , Tanaka S , Shimada A , et al. Insulin intervention in slowly progressive insulin-dependent (type 1) diabetes mellitus. J Clin Endocrinol Metab . 2008;93(6):2115–2121. doi:10.1210/jc.2007-2267 18397986
   PubMed Web of Science ®Google Scholar
• Hirata T , Shimada A , Morimoto J , Maruyama T . Slowly progressive type 1 diabetes treated with metformin for five years after onset. Intern Med . 2013;52(23):2635–2637. doi:10.2169/internalmedicine.52.9522 24292754
   PubMed Web of Science ®Google Scholar
• Zhao Y , Yang L , Xiang Y , et al. Dipeptidyl peptidase 4 inhibitor sitagliptin maintains beta-cell function in patients with recent-onset latent autoimmune diabetes in adults: one year prospective study. J Clin Endocrinol Metab . 2014;99(5):E876–E880. doi:10.1210/jc.2013-3633 24432999
   PubMed Web of Science ®Google Scholar
• Awata T , Shimada A , Maruyama T , et al. Possible long-term efficacy of sitagliptin, a dipeptidyl peptidase-4 inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the stage of non-insulin-dependency: an open-label randomized controlled pilot trial (SPAN-S). Diabetes Ther . 2017;8(5):1123–1134. doi:10.1007/s13300-017-0299-7 28929327
   PubMed Web of Science ®Google Scholar
• Nakanishi K , Kobayashi T , Miyashita H , et al. Relationships among residual beta cells, exocrine pancreas, and islet cell antibodies in insulin-dependent diabetes mellitus. Metabolism . 1993;42(2):196–203. doi:10.1016/0026-0495(93)90035-M 7682643
   PubMed Web of Science ®Google Scholar
• Nakanishi K , Kobayashi T , Miyashita H , et al. Exocrine pancreatic ductograms in insulin-dependent diabetes mellitus. Am J Gastroenterol . 1994;89(5):762–766.8172153
   PubMed Web of Science ®Google Scholar
• Shimada A , Imazu Y , Morinaga S , et al. T-cell insulitis found in anti-GAD65+ diabetes with residual beta-cell function. A case report. Diabetes Care . 1999;22(4):615–617. doi:10.2337/diacare.22.4.615 10189541
   PubMed Web of Science ®Google Scholar
• Signore A , Capriotti G , Chianelli M , et al. Detection of insulitis by pancreatic scintigraphy with 99mTc-labeled IL-2 and MRI in patients with LADA (Action LADA 10). Diabetes Care . 2015;38(4):652–658. doi:10.2337/dc14-0580 25665813
   PubMed Web of Science ®Google Scholar
• Kobayashi TNK , Sugimoto T , Murase T , Kosaka K . Histopathological changes of the pancreas in islet cell antibodies (ICA)-positive subjects before and the clinical onset of insulin-dependent diabetes melitus (IDDM). Diabetes . 1988;37:24A.
   Web of Science ®Google Scholar
• Kobayashi T , Aida K , Fukui T , et al. Pancreatic ductal hyperplasia/dysplasia with obstructive chronic pancreatitis: an association with reduced pancreatic weight in type 1 diabetes. Diabetologia . 2016;59(4):865–867. doi:10.1007/s00125-016-3867-x 26820736
   PubMed Web of Science ®Google Scholar
• Aida K , Fukui T , Jimbo E , et al. Distinct inflammatory changes of the pancreas of slowly progressive insulin-dependent (Type 1) Diabetes. Pancreas . 2018;47(9):1101–1109. doi:10.1097/MPA.0000000000001144 30192315
   PubMed Web of Science ®Google Scholar
• Campbell-Thompson ML , Atkinson MA , Butler AE , et al. The diagnosis of insulitis in human type 1 diabetes. Diabetologia . 2013;56(11):2541–2543. doi:10.1007/s00125-013-3043-5 24006089
   PubMed Web of Science ®Google Scholar
• Sugawara K , Kobayashi T , Nakanishi K , et al. Marked islet amyloid polypeptide-positive amyloid deposition: a possible cause of severely insulin-deficient diabetes mellitus with atrophied exocrine pancreas. Pancreas . 1993;8(3):312–315. doi:10.1097/00006676-199305000-00005 8483872
   PubMed Web of Science ®Google Scholar
• Kiss K , Baghy K , Spisak S , et al. Chronic hyperglycemia induces trans-differentiation of human pancreatic stellate cells and enhances the malignant molecular communication with human pancreatic cancer cells. PloS One . 2015;10(5):e0128059. doi:10.1371/journal.pone.0128059 26010611
   PubMed Web of Science ®Google Scholar
• Carstensen B , Read SH , Friis S , et al. Cancer incidence in persons with type 1 diabetes: a five-country study of 9000 cancers in type 1 diabetic individuals. Diabetologia . 2016;59(5):980–988. doi:10.1007/s00125-016-3884-9 26924393
   PubMed Web of Science ®Google Scholar
• Turner R , Stratton I , Horton V , et al. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet . 1997;350(9087):1288–1293. doi:10.1016/S0140-6736(97)03062-6 9357409
   PubMed Web of Science ®Google Scholar
• Graham J , Hagopian WA , Kockum I , et al. Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes . 2002;51(5):1346–1355. doi:10.2337/diabetes.51.5.1346 11978629
   PubMed Web of Science ®Google Scholar
• Lampasona V , Petrone A , Tiberti C , et al. Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4. Diabetes Care . 2010;33(1):104–108. doi:10.2337/dc08-2305 19808923
   PubMed Web of Science ®Google Scholar
• Kawasaki E . Type 1 diabetes and autoimmunity. Clin Pediatr Endocrinol . 2014;23(4):99–105. doi:10.1297/cpe.23.99 25374439
   PubMedGoogle Scholar
• Genovese S , Bazzigaluppi E , Goncalves D , et al. Clinical phenotype and beta-cell autoimmunity in Italian patients with adult-onset diabetes. Eur J Endocrinol . 2006;154(3):441–447. doi:10.1530/eje.1.02115 16498058
   PubMed Web of Science ®Google Scholar
• Tanaka S , Awata T , Shimada A . Clinical characteristics of slowly progressive insulin-dependent (type 1) diabetes mellitus (SPIDDM): 1st subcommittee report on SPIDDM, committee on type 1 diabetes, Japan Diabetes Society. J Japan Diab Soc . 2011;54(1):65–75.
   Google Scholar
• Hawa MI , Kolb H , Schloot N , et al. Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: action LADA 7. Diabetes Care . 2013;36(4):908–913. doi:10.2337/dc12-0931 23248199
   PubMed Web of Science ®Google Scholar
• Tanaka S , Okubo M , Nagasawa K , et al. Predictive value of titer of GAD antibodies for further progression of beta cell dysfunction in slowly progressive insulin-dependent (type 1) diabetes (SPIDDM). Diabetol Int . 2016;7(1):42–52. doi:10.1007/s13340-015-0211-5 30603242
   PubMedGoogle Scholar
• Murao S , Kondo S , Ohashi J , et al. Anti-thyroid peroxidase antibody, IA-2 antibody, and fasting C-peptide levels predict beta cell failure in patients with latent autoimmune diabetes in adults (LADA) – a 5-year follow-up of the Ehime study. Diabetes Res Clin Pract . 2008;80(1):114–121. doi:10.1016/j.diabres.2008.01.024 18342387
   PubMed Web of Science ®Google Scholar
• Buzzetti R , Di Pietro S , Giaccari A , et al. High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes. Diabetes Care . 2007;30(4):932–938. doi:10.2337/dc06-1696 17392553
   PubMed Web of Science ®Google Scholar
• Zampetti S , Capizzi M , Spoletini M , et al. GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6). J Clin Endocrinol Metab . 2012;97(10):3759–3765. doi:10.1210/jc.2012-2037 22865904
   PubMed Web of Science ®Google Scholar
• Tuomi T , Carlsson A , Li H , et al. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes . 1999;48(1):150–157. doi:10.2337/diabetes.48.1.150 9892237
   PubMed Web of Science ®Google Scholar
• Maioli M , Pes GM , Delitala G , et al. Number of autoantibodies and HLA genotype, more than high titers of glutamic acid decarboxylase autoantibodies, predict insulin dependence in latent autoimmune diabetes of adults. Eur J Endocrinol . 2010;163(4):541–549. doi:10.1530/EJE-10-0427 20603341
   PubMed Web of Science ®Google Scholar
• Zhou Z , Xiang Y , Ji L , et al. Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study. Diabetes . 2013;62(2):543–550. doi:10.2337/db12-0207 23086039
   PubMed Web of Science ®Google Scholar
• Falorni A , Gambelunghe G , Forini F , et al. Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus. J Clin Endocrinol Metab . 2000;85(1):309–316. doi:10.1210/jcem.85.1.6301 10634404
   PubMed Web of Science ®Google Scholar
• Achenbach P , Hawa MI , Krause S , et al. Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: action LADA 12. Diabetologia . 2018;61(7):1644–1649. doi:10.1007/s00125-018-4605-3 29619531
   PubMed Web of Science ®Google Scholar
• Kobayashi T , Tanaka S , Okubo M , Nakanishi K , Murase T , Lernmark A . Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes. J Clin Endocrinol Metab . 2003;88(10):4768–4775. doi:10.1210/jc.2002-021529 14557453
   PubMed Web of Science ®Google Scholar
• Jin P , Huang G , Lin J , Luo S , Zhou Z . Epitope analysis of GAD65 autoantibodies in adult-onset type 1 diabetes and latent autoimmune diabetes in adults with thyroid autoimmunity. Acta Diabetologica . 2011;48(2):149–155. doi:10.1007/s00592-010-0250-0 21212992
   PubMed Web of Science ®Google Scholar
• Maddaloni E , Lessan N , Al Tikriti A , Buzzetti R , Pozzilli P , Barakat MT . Latent autoimmune diabetes in adults in the United Arab Emirates: clinical features and factors related to insulin-requirement. PloS One . 2015;10(8):e0131837. doi:10.1371/journal.pone.0131837 26252955
   PubMed Web of Science ®Google Scholar
• Tiberti C , Giordano C , Locatelli M , et al. Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2. Diabetes . 2008;57(5):1276–1283. doi:10.2337/db07-0874 18332100
   PubMed Web of Science ®Google Scholar
• Buzzetti R , Spoletini M , Zampetti S , et al. Tyrosine phosphatase-related islet antigen 2(256-760) autoantibodies, the only marker of islet autoimmunity that increases by increasing the degree of BMI in obese subjects with type 2 diabetes. Diabetes Care . 2015;38(3):513–520. doi:10.2337/dc14-1638 25567348
   PubMed Web of Science ®Google Scholar
• Mishra R , Hodge KM , Cousminer DL , Leslie RD , Grant SFA . A global perspective of latent autoimmune diabetes in adults. Trends Endocrinol Metab . 2018;29(9):638–650. doi:10.1016/j.tem.2018.07.001 30041834
   PubMed Web of Science ®Google Scholar
• Park Y , Wintergerst KA , Zhou Z . Clinical heterogeneity of type 1 diabetes (T1D) found in Asia. Diabetes Metab Res Rev . 2017;33:7. doi:10.1002/dmrr.v33.7
   Web of Science ®Google Scholar
• American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care . 2019;42(Suppl 1):S13–S28. doi:10.2337/dc19-S002 30559228
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Children and adolescents: standards of medical care in diabetes-2019. Diabetes Care . 2019;42(Suppl 1):S148–S164. doi:10.2337/dc19-S013 30559239
   PubMed Web of Science ®Google Scholar
• Oikawa Y , Shimada A , Awata T , et al. Clinical features of cases of seroconversion of anti-glutamic acid decarboxylase antibody during the clinical course of type 2 diabetes: a nationwide survey in Japan. Diabetol Int . 2017;8(3):306–315. doi:10.1007/s13340-017-0312-4 30603336
   PubMed Web of Science ®Google Scholar
• Fourlanos S , Dotta F , Greenbaum CJ , et al. Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia . 2005;48(11):2206–2212. doi:10.1007/s00125-005-1960-7 16193284
   PubMed Web of Science ®Google Scholar
• Kawasaki E , Maruyama T , Imagawa A , et al. Diagnostic criteria for acute-onset type 1 diabetes mellitus (2012): report of the Committee of Japan Diabetes Society on the research of fulminant and acute-onset type 1 diabetes mellitus. J Diabetes Invest . 2014;5(1):115–118. doi:10.1111/jdi.12119
   Web of Science ®Google Scholar
• Hjort R , Alfredsson L , Andersson T , et al. Family history of type 1 and type 2 diabetes and risk of latent autoimmune diabetes in adults (LADA). Diabetes Metab . 2017;43(6):536–542. doi:10.1016/j.diabet.2017.05.010 28669512
   PubMed Web of Science ®Google Scholar
• Cervin C , Lyssenko V , Bakhtadze E , et al. Genetic similarities between latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes. Diabetes . 2008;57(5):1433–1437. doi:10.2337/db07-0299 18310307
   PubMed Web of Science ®Google Scholar
• Pettersen E , Skorpen F , Kvaloy K , Midthjell K , Grill V . Genetic heterogeneity in latent autoimmune diabetes is linked to various degrees of autoimmune activity: results from the Nord-Trondelag Health Study. Diabetes . 2010;59(1):302–310. doi:10.2337/db09-0923 19833889
   PubMed Web of Science ®Google Scholar
• Howson JM , Rosinger S , Smyth DJ , Boehm BO , Todd JA . Genetic analysis of adult-onset autoimmune diabetes. Diabetes . 2011;60(10):2645–2653. doi:10.2337/db11-0364 21873553
   PubMed Web of Science ®Google Scholar
• Mishra R , Chesi A , Cousminer DL , et al. Relative contribution of type 1 and type 2 diabetes loci to the genetic etiology of adult-onset, non-insulin-requiring autoimmune diabetes. BMC Medicine . 2017;15(1):88. doi:10.1186/s12916-017-0846-0 28438156
   PubMed Web of Science ®Google Scholar
• Kawabata Y , Ikegami H , Awata T , et al. Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset. Diabetologia . 2009;52(12):2513–2521. doi:10.1007/s00125-009-1539-9 19812988
   PubMed Web of Science ®Google Scholar
• Desai M , Zeggini E , Horton VA , et al. An association analysis of the HLA gene region in latent autoimmune diabetes in adults. Diabetologia . 2007;50(1):68–73. doi:10.1007/s00125-006-0513-z 17143607
   PubMed Web of Science ®Google Scholar
• Luo S , Lin J , Xie Z , et al. HLA genetic discrepancy between latent autoimmune diabetes in adults and type 1 diabetes: LADA China study no. 6. J Clin Endocrinol Metab . 2016;101(4):1693–1700. doi:10.1210/jc.2015-3771 26866570
   PubMed Web of Science ®Google Scholar
• Andersen MK , Lundgren V , Turunen JA , et al. Latent autoimmune diabetes in adults differs genetically from classical type 1 diabetes diagnosed after the age of 35 years. Diabetes Care . 2010;33(9):2062–2064. doi:10.2337/dc09-2188 20805278
   PubMed Web of Science ®Google Scholar
• Cousminer DL , Ahlqvist E , Mishra R , et al. First genome-wide association study of latent autoimmune diabetes in adults reveals novel insights linking immune and metabolic diabetes. Diabetes Care . 2018;41(11):2396–2403. doi:10.2337/dc18-1032 30254083
   PubMed Web of Science ®Google Scholar
• Takeda H , Kawasaki E , Shimizu I , et al. Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study). Diabetes Care . 2002;25(6):995–1001. doi:10.2337/diacare.25.6.995 12032105
   PubMed Web of Science ®Google Scholar
• Haller K , Kisand K , Pisarev H , et al. Insulin gene VNTR, CTLA-4 +49A/G and HLA-DQB1 alleles distinguish latent autoimmune diabetes in adults from type 1 diabetes and from type 2 diabetes group. Tissue Antigens . 2007;69(2):121–127. doi:10.1111/tan.2007.69.issue-2 17257313
   PubMedGoogle Scholar
• Cosentino A , Gambelunghe G , Tortoioli C , Falorni A . CTLA-4 gene polymorphism contributes to the genetic risk for latent autoimmune diabetes in adults. Ann N Y Acad Sci . 2002;958:337–340. doi:10.1111/j.1749-6632.2002.tb03000.x 12021137
   PubMed Web of Science ®Google Scholar
• Van der Auwera BJ , Vandewalle CL , Schuit FC , et al. CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. The Belgian diabetes registry. Clin Experiment Immunol . 1997;110(1):98–103. doi:10.1111/cei.1997.110.issue-1
   Web of Science ®Google Scholar
• Ikegami H , Awata T , Kawasaki E , et al. The association of CTLA4 polymorphism with type 1 diabetes is concentrated in patients complicated with autoimmune thyroid disease: a multicenter collaborative study in Japan. J Clin Endocrinol Metab . 2006;91(3):1087–1092. doi:10.1210/jc.2005-1407 16352685
   PubMed Web of Science ®Google Scholar
• Kawasaki E , Awata T , Ikegami H , et al. Systematic search for single nucleotide polymorphisms in a lymphoid tyrosine phosphatase gene (PTPN22): association between a promoter polymorphism and type 1 diabetes in Asian populations. Am J Med Genet A . 2006;140(6):586–593. doi:10.1002/ajmg.a.31124 16470599
   PubMed Web of Science ®Google Scholar
• Awata T , Kawasaki E , Ikegami H , et al. Insulin gene/IDDM2 locus in Japanese type 1 diabetes: contribution of class I alleles and influence of class I subdivision in susceptibility to type 1 diabetes. J Clin Endocrinol Metab . 2007;92(5):1791–1795. doi:10.1210/jc.2006-2242 17341563
   PubMed Web of Science ®Google Scholar
• Shimada A , Kanazawa Y , Motohashi Y , et al. Evidence for association between vitamin D receptor BsmI polymorphism and type 1 diabetes in Japanese. J Autoimmunity . 2008;30(4):207–211. doi:10.1016/j.jaut.2007.09.002 17959356
   PubMed Web of Science ®Google Scholar
• Kawasaki E , Awata T , Ikegami H , et al. Genetic association between the interleukin-2 receptor-alpha gene and mode of onset of type 1 diabetes in the Japanese population. J Clin Endocrinol Metab . 2009;94(3):947–952. doi:10.1210/jc.2008-1596 19106270
   PubMed Web of Science ®Google Scholar
• Andersen MK , Sterner M , Forsen T , et al. Type 2 diabetes susceptibility gene variants predispose to adult-onset autoimmune diabetes. Diabetologia . 2014;57(9):1859–1868. doi:10.1007/s00125-014-3287-8 24906951
   PubMed Web of Science ®Google Scholar
• Lukacs K , Hosszufalusi N , Dinya E , Bakacs M , Madacsy L , Panczel P . The type 2 diabetes-associated variant in TCF7L2 is associated with latent autoimmune diabetes in adult Europeans and the gene effect is modified by obesity: a meta-analysis and an individual study. Diabetologia . 2012;55(3):689–693. doi:10.1007/s00125-011-2378-z 22109281
   PubMed Web of Science ®Google Scholar
• Bottazzo GF , Bosi E , Cull CA , et al. IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71). Diabetologia . 2005;48(4):703–708. doi:10.1007/s00125-005-1691-9 15765222
   PubMed Web of Science ®Google Scholar
• Zampetti S , Campagna G , Tiberti C , et al. High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7). Eur J Endocrinol . 2014;171(6):697–704.25213702
   PubMed Web of Science ®Google Scholar
• Verge CF , Gianani R , Kawasaki E , et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes . 1996;45(7):926–933. doi:10.2337/diab.45.7.926 8666144
   PubMed Web of Science ®Google Scholar
• Liu L , Li X , Xiang Y , et al. Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3). Diabetes Care . 2015;38(1):16–21. doi:10.2337/dc14-1770 25336751
   PubMed Web of Science ®Google Scholar
• Kobayashi T , Tanaka S , Shimada A , Maruyama T . High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes: response to Buzzetti et al. Diabetes Care . 2007;30(11):e126 author reply e127. doi:10.2337/dc07-1104 17965310
   PubMedGoogle Scholar
• Sasamori H , Fukui T , Hayashi T , et al. Analysis of pancreatic volume in acute-onset, slowly-progressive and fulminant type 1 diabetes in a Japanese population. J Diabetes Invest . 2018;9(5):1091–1099. doi:10.1111/jdi.12816
   Web of Science ®Google Scholar
• Nakanishi K , Matsumura T , Kobayashi T . Slowly progressive IDDM and malnutrition-related diabetes. Diabetes Care . 1996;19(2):178. doi:10.2337/diacare.19.2.178a
   Web of Science ®Google Scholar
• Hoshina S , Miura J , Uchigata Y . Relationship between HLA haplotype and BMI change in Japanese slowly progressive type 1 diabetes patients. Diabetes Res Clin Pract . 2017;124:81–83. doi:10.1016/j.diabres.2016.12.006 28110239
   PubMed Web of Science ®Google Scholar
• Fourlanos S , Elkassaby S , Varney MD , Colman PG , Harrison LC . Higher body mass index in adults at diagnosis of the slowly progressive form of type 1 diabetes mellitus is associated with lower risk HLA genes. Diabetes Res Clin Pract . 2014;104(3):e69–e71. doi:10.1016/j.diabres.2014.03.009 24698405
   PubMed Web of Science ®Google Scholar
• Lee SH , Kwon HS , Yoo SJ , et al. Identifying latent autoimmune diabetes in adults in Korea: the role of C-peptide and metabolic syndrome. Diabetes Res Clin Pract . 2009;83(2):e62–e65. doi:10.1016/j.diabres.2008.11.031 19166794
   PubMedGoogle Scholar
• Qi X , Sun J , Wang J , et al. Prevalence and correlates of latent autoimmune diabetes in adults in Tianjin, China: a population-based cross-sectional study. Diabetes Care . 2011;34(1):66–70. doi:10.2337/dc10-0488 20876205
   PubMed Web of Science ®Google Scholar
• Bosi EP , Garancini MP , Poggiali F , Bonifacio E , Gallus G . Low prevalence of islet autoimmunity in adult diabetes and low predictive value of islet autoantibodies in the general adult population of northern Italy. Diabetologia . 1999;42(7):840–844. doi:10.1007/s001250051235 10440126
   PubMed Web of Science ®Google Scholar
• Zinman B , Kahn SE , Haffner SM , O’Neill MC , Heise MA , Freed MI . Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe. Diabetes . 2004;53(12):3193–3200. doi:10.2337/diabetes.53.12.3193 15561950
   PubMed Web of Science ®Google Scholar
• Radtke MA , Midthjell K , Nilsen TI , Grill V . Heterogeneity of patients with latent autoimmune diabetes in adults: linkage to autoimmunity is apparent only in those with perceived need for insulin treatment: results from the Nord-Trondelag Health (HUNT) study. Diabetes Care . 2009;32(2):245–250. doi:10.2337/dc08-1468 19001190
   PubMed Web of Science ®Google Scholar
• Leslie RD , Kolb H , Schloot NC , et al. Diabetes classification: grey zones, sound and smoke: action LADA 1. Diabetes Metab Res Rev . 2008;24(7):511–519. doi:10.1002/dmrr.v24:7 18615859
   PubMed Web of Science ®Google Scholar
• Guglielmi C , Palermo A , Pozzilli P . Latent autoimmune diabetes in the adults (LADA) in Asia: from pathogenesis and epidemiology to therapy. Diabetes Metab Res Rev . 2012;28(Suppl 2):40–46. doi:10.1002/dmrr.2345
   Web of Science ®Google Scholar
• Myhill P , Davis WA , Bruce DG , Mackay IR , Zimmet P , Davis TM . Chronic complications and mortality in community-based patients with latent autoimmune diabetes in adults: the Fremantle Diabetes Study. Diabet Med . 2008;25(10):1245–1250. doi:10.1111/j.1464-5491.2008.02562.x 19046207
   PubMed Web of Science ®Google Scholar
• Wang C , Lu J , Lu W , et al. Evaluating peripheral nerve function in asymptomatic patients with type 2 diabetes or latent autoimmune diabetes of adults (LADA): results from nerve conduction studies. J Diabetes Complications . 2015;29(2):265–269. doi:10.1016/j.jdiacomp.2014.11.001 25434703
   PubMed Web of Science ®Google Scholar
• Buzzetti R , Zampetti S , Maddaloni E . Adult-onset autoimmune diabetes: current knowledge and implications for management. Nature Rev Endocrinol . 2017;13(11):674–686. doi:10.1038/nrendo.2017.99 28885622
   PubMed Web of Science ®Google Scholar
• Pozzilli P , Pieralice S . Latent autoimmune diabetes in adults: current status and new horizons. Endocrinol Metab . 2018;33(2):147–159. doi:10.3803/EnM.2018.33.2.147
   Web of Science ®Google Scholar
• Isomaa B , Almgren P , Henricsson M , et al. Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA). Diabetes Care . 1999;22(8):1347–1353. doi:10.2337/diacare.22.8.1347 10480781
   PubMed Web of Science ®Google Scholar
• Roh MO , Jung CH , Kim BY , Mok JO , Kim CH . The prevalence and characteristics of latent autoimmune diabetes in adults (LADA) and its relation with chronic complications in a clinical department of a university hospital in Korea. Acta Diabetologica . 2013;50(2):129–134. doi:10.1007/s00592-010-0228-y 20953640
   PubMed Web of Science ®Google Scholar
• Arikan E , Sabuncu T , Ozer EM , Hatemi H . The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus. J Diabetes Complications . 2005;19(5):254–258. doi:10.1016/j.jdiacomp.2005.02.004 16112499
   PubMed Web of Science ®Google Scholar
• Olsson L , Grill V , Midthjell K , Ahlbom A , Andersson T , Carlsson S . Mortality in adult-onset autoimmune diabetes is associated with poor glycemic control: results from the HUNT Study. Diabetes Care . 2013;36(12):3971–3978. doi:10.2337/dc13-0564 24130367
   PubMed Web of Science ®Google Scholar
• Nakanishi K , Kobayashi T , Miyashita H , et al. Relationships among islet cell antibodies, residual beta-cell function, and metabolic control in patients with insulin-dependent diabetes mellitus of long duration: use of a sensitive C-peptide radioimmunoassay. Metabolism . 1990;39(9):925–930. doi:10.1016/0026-0495(90)90302-S 2202883
   PubMed Web of Science ®Google Scholar
• Nakanishi K , Kobayashi T , Inoko H , Tsuji K , Murase T , Kosaka K . Residual beta-cell function and HLA-A24 in IDDM. Markers of glycemic control and subsequent development of diabetic retinopathy. Diabetes . 1995;44(11):1334–1339. doi:10.2337/diab.44.11.1334 7589833
   PubMed Web of Science ®Google Scholar
• Kobayashi T , Nakanishi K , Murase T , Kosaka K . Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes . 1996;45(5):622–626. doi:10.2337/diab.45.5.622 8621013
   PubMed Web of Science ®Google Scholar
• Nishimura A , Nagasawa K , Okubo M , Kobayashi T , Mori Y . Exponential increase of glutamic acid decarboxylase (GAD) antibody titer after initiating and stopping insulin in a patient with slowly progressive type 1 diabetes. Endocr J . 2015;62(12):1077–1082. doi:10.1507/endocrj.EJ15-0378 26440526
   PubMed Web of Science ®Google Scholar
• Brophy S , Davies H , Mannan S , Brunt H , Williams R . Interventions for latent autoimmune diabetes (LADA) in adults. Cochrane Database Syst Rev . 2011;(9):Cd006165.21901702
   PubMed Web of Science ®Google Scholar
• Varga T , Somogyi A , Barna G , et al. Higher serum DPP-4 enzyme activity and decreased lymphocyte CD26 expression in type 1 diabetes. Pathol Oncol Res . 2011;17(4):925–930. doi:10.1007/s12253-011-9404-9 21785903
   PubMed Web of Science ®Google Scholar
• Johansen OE , Boehm BO , Grill V , et al. C-peptide levels in latent autoimmune diabetes in adults treated with linagliptin versus glimepiride: exploratory results from a 2-year double-blind, randomized, controlled study. Diabetes Care . 2014;37(1):e11–e12. doi:10.2337/dc13-1523 24356601
   PubMed Web of Science ®Google Scholar
• Buzzetti R , Pozzilli P , Frederich R , Iqbal N , Hirshberg B . Saxagliptin improves glycaemic control and C-peptide secretion in latent autoimmune diabetes in adults (LADA). Diabetes Metab Res Rev . 2016;32(3):289–296. doi:10.1002/dmrr.v32.3 26385269
   PubMed Web of Science ®Google Scholar
• Kim SJ , Nian C , McIntosh CH . Sitagliptin (MK0431) inhibition of dipeptidyl peptidase IV decreases nonobese diabetic mouse CD4+ T-cell migration through incretin-dependent and -independent pathways. Diabetes . 2010;59(7):1739–1750. doi:10.2337/db09-1618 20368408
   PubMed Web of Science ®Google Scholar
• Tian L , Gao J , Hao J , et al. Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor. Endocrinology . 2010;151(7):3049–3060. doi:10.1210/en.2010-0068 20444936
   PubMed Web of Science ®Google Scholar
• Kawano Y , Irie J , Nakatani H , Yamada S . Pioglitazone might prevent the progression of slowly progressive type 1 diabetes. Intern Med . 2009;48(12):1037–1039. doi:10.2169/internalmedicine.48.1990 19525594
   PubMed Web of Science ®Google Scholar
• Shimada A , Shigihara T , Okubo Y , Katsuki T , Yamada Y , Oikawa Y . Pioglitazone may accelerate disease course of slowly progressive type 1 diabetes. Diabetes Metab Res Rev . 2011;27(8):951–953. doi:10.1002/dmrr.v27.8 22069291
   PubMed Web of Science ®Google Scholar